Browsing by Author Espinoza, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2014Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular diseaseCaterson, Ian; Espinoza, David; Gebski, Val; Ivers, Lucy; Seimon, Radhika; Coutinho, Walmir; Finer, N; James, W; Legler, U F; Sharma, Arya; Boden Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Boden InstituteChanges in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease, International Journal of Obesity, vol.38, 9, 2014,pp 1165-1171
2015Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trialCaterson, Ian; Espinoza, David; Gebski, Val; Seimon, Radhika; Sweeting, Arianne Natasha; Coutinho, Walmir; Finer, Nick; James, W; Legler, U F; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, Luc; Boden Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Boden Institute; Boden InstituteChanges in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial, International Journal of Obesity, vol.39, 5, 2015,pp 849-857
2017Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatmentEspinoza, David; Haber, Paul; Hallinan, Richard; Lintzeris, Nicholas; Veillard, Anne-Sophie; Elsayed, Mahmoud; NH&MRC Clinical Trials Centre; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction Medicine; Central Clinical School: Psychological Medicine; NH&MRC Clinical Trials CentreConstipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment, Drug and Alcohol Dependence, vol.181, N/A, 2017,pp 132-139
2017Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?Butow, Phyllis; Cust, Anne; Espinoza, David; Kirk, Judy; Morton, Rachael; Newson, Ainsley; Smit, Amelia; Dunlop, Kate; Keogh, L; Psychology; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: Public HealthDoes personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?, British Journal of Dermatology, vol.177, 3, 2017,pp 779-790
2015EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma.Espinoza, David; Hudson, Amanda; Long, Anne; Martin, Andrew; Pavlakis, Nick; Stockler, Martin; Thompson, John; Yip, Sonia; Azad, A; Davis, I D; Goldstein, David; Harrision, M; Harvie, R; Jovanovic, L; Kannourakis, G; Kichenadasse, G; Lowenthal, Raymond M.; Nelson, C C; Shapiro, J; Steer, C; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; NH&MRC Clinical Trials CentreEVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma., Annals of Oncology, vol.26, 6, 2015,pp 1118-1123
2017Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastomaBarnes, Elizabeth; Espinoza, David; King, Madeleine; Sawkins, Kate; Simes, Robert John; Cher, L; Field, Kathryn; Hovey, Elizabeth; Nowak, Anna K.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma, Journal of Neuro-Oncology, vol.133, N/A, 2017,pp 623-631
2015A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialBoyer, Michael; Chan, Matthew; Chinchen, Sarah; Coskinas, Xanthi; Espinoza, David; Pavlakis, Nick; Stockler, Martin; Tognela, Annette; Veillard, Anne-Sophie; Abdi, E; Begbie, S; Boyce, Adam; Briscoe, Karen; Crombie, C.; Davidson, A; et al, Various; Huighes, B G M; Lewis, C R; Long, J; Varma, S; Central Clinical School: Medicine; Northern Clinical School: Melanoma Institute of Australia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreA phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial, Annals of Oncology, vol.26, 11, 2015,pp 2280-2286
2017Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True LymphedemaEspinoza, David; Gebski, Val; Mister, Rebecca; Simes, Robert John; Stockler, Martin; Campbell, Ian; Gill, Peter; Ung, Owen; Wetzig, Neil; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema, Annals of Surgical Oncology, vol.24, 4, 2017,pp 1064-1070